Phase II trial of a single weekly intravenous dose of ranpirnase in patients with unresectable malignant mesothelioma. [electronic resource]

By: Contributor(s): Producer: 20020201Description: 274-81 p. digitalISSN:
  • 0732-183X
Subject(s): Online resources: In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 20
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

There are no comments on this title.

to post a comment.